{"id":3451,"date":"2024-02-05T17:04:11","date_gmt":"2024-02-05T17:04:11","guid":{"rendered":"https:\/\/news2shorts.com\/index.php\/2024\/02\/05\/novo-nordisk-parent-buys-us-drug-firm-for-16-5bn-to-expand-wegovy-supply\/"},"modified":"2024-02-05T17:04:11","modified_gmt":"2024-02-05T17:04:11","slug":"novo-nordisk-parent-buys-us-drug-firm-for-16-5bn-to-expand-wegovy-supply","status":"publish","type":"post","link":"https:\/\/news2shorts.com\/index.php\/2024\/02\/05\/novo-nordisk-parent-buys-us-drug-firm-for-16-5bn-to-expand-wegovy-supply\/","title":{"rendered":"Novo Nordisk parent buys US drug firm for $16.5bn to expand Wegovy supply"},"content":{"rendered":"<p>Company to acquire three sites from Catalent amid runaway demand for weight-loss drug<\/p>\n<p>The explosion in demand for the weight loss drug Wegovy has led to the holding company behind its maker, Novo Nordisk, buying a leading US-based drugmaker for $16.5bn (\u00a313.2bn) to increase capacity.<\/p>\n<p>Novo Holdings is to buy the New Jersey-based pharmaceutical firm Catalent, and then immediately sell three of its sites for $11bn in US and Europe to Wegovy Novo Nordisk, which will increase its ability to match supply with growing demand.<\/p>\n<p> <a href=\"https:\/\/www.theguardian.com\/business\/2024\/feb\/05\/novo-nordisk-us-drug-firm-wegovy-catalent-weight-loss\">Continue reading&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Company to acquire three sites from Catalent amid runaway demand for weight-loss drug The explosion in demand for the weight loss drug Wegovy has led to the holding company behind its maker, Novo Nordisk, buying a leading US-based drugmaker for $16.5bn (\u00a313.2bn) to increase capacity. Novo Holdings is to buy the New Jersey-based pharmaceutical firm &#8230; <a title=\"Novo Nordisk parent buys US drug firm for $16.5bn to expand Wegovy supply\" class=\"read-more\" href=\"https:\/\/news2shorts.com\/index.php\/2024\/02\/05\/novo-nordisk-parent-buys-us-drug-firm-for-16-5bn-to-expand-wegovy-supply\/\" aria-label=\"Read more about Novo Nordisk parent buys US drug firm for $16.5bn to expand Wegovy supply\">Read more<\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-3451","post","type-post","status-publish","format-standard","hentry","category-blog"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts\/3451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/comments?post=3451"}],"version-history":[{"count":0,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts\/3451\/revisions"}],"wp:attachment":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/media?parent=3451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/categories?post=3451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/tags?post=3451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}